Oppilan Pharma Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Subsidiary
- Established
- 2015-01-01
- Employees
- 1
- Market Cap
- -
- Website
- https://oppilan.com
VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
- First Posted Date
- 2021-12-14
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Oppilan Pharma Ltd
- Target Recruit Count
- 213
- Registration Number
- NCT05156125
- Locations
- 🇵🇱
Local Site # 616011, Piotrków Trybunalski, Poland
🇵🇱Local Site # 616006, Warsaw, Poland
🇸🇰Local Site # 703002, Šahy, Slovakia
A PK Dose Proportionality Study of OPL-002 in Healthy Volunteers
- First Posted Date
- 2020-06-30
- Last Posted Date
- 2021-05-28
- Lead Sponsor
- Oppilan Pharma Ltd
- Target Recruit Count
- 12
- Registration Number
- NCT04451811
- Locations
- 🇬🇧
Celerion, Belfast, Northern Ireland, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath